Indication

For the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders (NDM).

Medicine details

Medicine name:
mexiletine hydrochloride (Namuscla)
SMC ID:
SMC2241
Pharmaceutical company
Lupin Healthcare
BNF chapter
Central nervous system
Submission type
Full
Status
Publication due date:
09 March 2020
SMC meeting date:
04 February 2020
Patient group submission deadline:
02 December 2019